THE ONLY PROVIDER OF SCIENTIFICALLY VALID PATIENT CHART AUDIT / TREATING PHYSICIAN RESEARCH

We’d Like to Discuss Product-Optimizing Case Studies Like This One:

Resizing a Market

ID minimum # Dx & Tx, based on actual transactions

        The major study objectives were to:

  • Increase confidence in updated market size projections for the client to share internally and externally.
  • Develop a valuable baseline database against which periodic future comparisons could detect important changes in key physician practice and treatment patterns.
  • Anchor our estimates on a commercial ICD claims database after we determined how to fill in gaps and correct errors and other problems with claims data.

Fill in known gaps in transaction-based estimates

Update projections as appropriate

Case 1: Current Treatments and Best Opportunities
               for a forthcoming first-in-class treatment
Case 2
: Move from Pre-Launch to Blockbuster

               
in a crowded market
​Case 3:
 Competitive Landscape of Usage Tracking

               plus demand-forecasting updates & support 

Case 4: Mapping Patient Flow and Dosing Stage
         of a drug for a target condition 

Case 5: Measuring Adherence to Guidelines
         for treating cancer; a 5-nation comparison

Click links below to learn how we met other clients' business needs:

Epidemiologic studies:

  • A health needs assessment of Coachella Valley, California
  • Market sizing for conditions treated by several orphan drugs

   

Delphi method consensus building:

Our collaborative estimating and forecasting methodology
combines independent analysis with maximum use of feedback for building consensus among world-recognized experts who interact anonymously.

  • Estimating annual prevalence of diseases in nations where secondardy data are lacking
       

Econometric modeling:

  • Optimal sales force sizing
  • Valuing certain market assets in a potential company buyout
  • Determining whether a client should buy a generic manufacturer, and at what price
  • Development of a desktop system for marketing staff to determine relative contributions of sales force vs. contract effects
  • Relative financial contributions of client's sales force vs. that of a contractor marketing the client's drug
  • Forecast of likely company sales by product line  
     

Focus groups/ATU studies:

We have enhanced quantitative studies with qualitative services such as:

  • Branding, messaging, buyer preference focus groups
  • Pre-launch qualitative research for a new atypical antipsychotic and continued tracking/market strategy evaluation studies

© 2014-2017 Clarity Pharma Research LLC  |  All Rights Reserved​ Privacy Policy
To learn more about our services, call (864) 208-0078 or contact information@claritypharma.com.
Subscribe to our newsletter at: http://eepurl.com/ovQcb